Target intelligence / Profile preview

Ataxin-10 (ATXN10)

Target
ATXN10
Molecular classification
Other (member of Ataxin protein family; not an enzyme, receptor, transporter, ion channel, or transcription factor)
01

Overview

Ataxin-10 is a cytoplasmic protein encoded by the ATXN10 gene, best known for its association with spinocerebellar ataxia type 10 (SCA10), a neurodegenerative disorder caused by expansion of a pentanucleotide (ATTCT) repeat in its intronic region[1][3][5]. Ataxin-10 plays roles in neuron survival, neuronal differentiation, and neuritogenesis, partially through activation of the mitogen-activated protein kinase (MAPK) cascade and interaction with G protein subunits[1][3][4]. It is also essential for proper cytokinesis and coordinates cell cycle events, interacting with mitotic regulators such as polo-like kinase 1 (Plk1) and Aurora B kinase[1]. In SCA10, toxic intronic RNA expansions sequester RNA-binding proteins, leading to RNA processing defects and apoptosis. Ataxin-10 is broadly expressed, with particular importance during embryonic development and in the nervous system. There are no known direct interacting drugs as of the latest reports, and it is not currently a validated therapeutic target.

Other names
Ataxin-10SCA10E46LFLJ37990ATX10Brain protein E46 homologSpinocerebellar ataxia type 10 proteinHUMEEPataxin-10brain protein E46 homologspinocerebellar ataxia type 10 protein
02

Biological functions

Neuron survivalNeuron differentiationNeuritogenesisRegulation of cytokinesisCell divisionCell cycleActivation of MAP kinase cascade
03

Disease associations

Neurodegenerative disease (Spinocerebellar ataxia type 10)possibly other neuronal/neurological disorders

Beyond the preview

Go deeper on Ataxin-10 (ATXN10).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ataxin-10 (ATXN10).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call